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threatening complications. Prophylactic acyclovir is routinely
given to patients, which has lessened the prevalence of HSV. When
HSV does not respond to acyclovir, or is found to be resistant to
acyclovir, foscarnet has proven to be a powerful antiviral agent;
however, foscarnet can be very toxic to renal function. This poster
will include general information on this virus and treatments used
to control it, along with nursing considerations for the care of the
pediatric transplantation patient with a reactivation of HSV infec-
tion.
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ASSESSING FOR NUTRITIONAL RISK FACTORS ON A BONE MARROW
TRANSPLANTATION UNIT
Szewczyk, N.A. University of Texas M.D. Anderson Cancer Center,
Houston, TX.
The Assessing for Nutritional Risk Factors clinical project took
place in a bone marrow transplantation (BMT) unit in San Anto-
nio, Texas. The purpose of this project is to develop an assessment
tool for identifying individuals in a BMT inpatient unit who are at
risk for developing complications secondary to inadequate nutri-
tional intake. A secondary goal of this project is to increase nutri-
tional assessment documentation by the nursing staff in this unit.
The Nutritional Risk Assessment Tool (NRAT) preevaluation data
were obtained by interviewing the staff regarding their opinions
about malnutrition in the oncology patient population and the
usefulness of the NRAT on the BMT unit. In addition, the doc-
umentation rate of calorie counts and weights was collected for the
3 months before this project’s implementation.
Results showed a signiﬁcant increase in calorie count documen-
tation and an overall increase in the staff’s awareness about mal-
nutrition in this patient population. The outcomes of this project
include (1) increased awareness of nutritional deﬁcits in the BMT
population in multidisciplinary team members including RNs,
PCAs, and MDs; (2) increased documentation of inadequate di-
etary assessment; and (3) pilot testing of a nutritional assessment
tool.
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SUBJECTIVE SYMPTOMS AND PERFORMANCE STATUS OF SURVIVORS
OF HEMATOPOIETIC STEM CELL TRANSPLANTATION
Choi, S.E., Kim, K.S., Bok, G.N. St. Mary’s Hospital, Catholic HSCT
Center, Seoul, Korea.
Hematopoietic stem cell transplantation(HSCT) is a widely
used treatments for hematologic malignancies and has often
ensured long-term survival of HSCT patients. Concern for
“quality of life” in HSCT patients has increased, and a quality of
life issue becomes recognized as an important outcome of the
treatment. These patients and their families are expecially in-
terested in when they are going to return to “normal” life and
how much time it will take. Therefore, we examined post-
HSCT patients’ subjective symptoms and performance status as
indicators of quality of life.
The ﬁnal samples consisted of 250 patients who had undergone
HSCT at a single center from 1990 to October 2003 and survived
at least 1 year after receiving HSCT. Of the 250 patients, 142 were
male and 108 were female, with a mean age of 33 years. Of the total
patients, 113 patients (59.5%) had been married and 73 patients
(38.4%) wre been single at the time of HSCT.
The patients completed a questionnaire mailed by the research-
ers. Subjective symptom subscales include fatigue, nausea and vom-
iting, pain, dyspnea, insomnia, loss of appetite, constipation, diar-
rhea, and ﬁnancial difﬁculties. The scores of subjective symptoms
range from 0 to 100, with higher scores indicating more severe
symptoms. Performance status was measured in patients over age
16 years using the Karnofsky score and in those under age 16 years
using the Lansky scale.
The median score of subjective symptom after HSCT was 12.2
(range, 0–68.8). The subjective symptom which many of the pa-
tients complained about was ﬁnancial difﬁculties (median, 40),
followed by fatigue (median, 30) and insomnia (median, 17.3). By
3 years, those symptoms had gradually decreased.
The median score of performance status 1–3 years after HSCT
was 80%, but 3 years later it was 90%, indicating that as time went
on, performance status improved. Among the 114 patients who had
been employed before HSCT, 81 (71.1%) continued to work but
30 (26.3%) became unemployed after HSCT. The average time to
return to school and work was 1.27 years (range, 1 to 7 years);
within 2 years after HSCT, 80 patients (72.7%) returned.
In conclusion, those ﬁndings can suggest that until 3 years fol-
lowing HSCT, there should be steady management of physical
symptoms and complications which post-HSCT patients possibly
experience.
Table. Subjective Symptoms and Performance Status after HSCT
1–<2
Year
2–<3
Year
3–4
< Year
4–<5
Year
5 <
Year
Financial
Difficulties 43.00 50.60 38.30 35.70 28.70
Fatigue 38.80 40.60 37.90 27.50 33.40
Subjective
Symptoms 18.90 22.20 15.20 12.00 12.90
Performance
Status 80.10 81.70 90.00 93.20 93.40
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TREATMENT OPTIONS AND NURSING CARE FOR THE PEDIATRIC
APLASTIC ANEMIA PATIENT REQURIRING BONE MARROW OR STEM
CELL TRANSPLANTATION
Baker, J.H., Frey, M.A., Kurtzberg, J. Duke University Medical Cen-
ter, Durham, NC.
Aplastic anemia is a rare, potentially lethal disease that occurs
when the bone marrow stops making enough blood cells. The
condition results in complete bone marrow failure and aplasia.
Common life threatening complications include infection, bleed-
ing, and anemia. The cause of aplastic anemia is unknown but may
be linked to injury to the bone marrow from radiation, chemicals,
viruses, and other causes. The initial diagnosis of aplastic anemia is
often a medical emergency requiring hospitalization and isolation.
The diagnosis is typically made via peripheral blood sampling and
a bone marrow aspirate. Supportive care during the initial period
typically consists of blood component replacement and antimicro-
bial coverage to reduce and treat life-threatening infections. The
gold standard of cure for these patients is bone marrow or stem cell
transplantation. The Duke Pediatric Stem Cell Transplant Pro-
gram has performed 22 transplantations on children with aplastic
anemia. The aims ofthis abstract are as follows:
1. To deﬁne and describe the potential causes of aplastic anemia.
2. To describe the symptoms associated with the onset of the disease, as
well as the sequelae seen with the progression of this disease.
3. To review the latest treatment options, including a detailed analysis of
bone marrow and stem cell transplantation in this patient population.
4. To provide a detailed description of the Duke Pediatric Stem Cell
Transplantation experience regarding this patient population.
5. To provide statistics on the outcomes of transplantation in this group
of children.
6. To identify nursing strategies for the care and support of these patients.
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OPEN ALL NIGHT? VISITING HOURS ON BONE MARROW TRANSPLAN-
TATION UNITS
Rees, L.F. H. Lee Mofﬁtt Cancer Center & Research Institute, Tampa,
FL.
Established visitation policies exist to provide a safe environment,
yet they may be at odds with the psychological needs of patients.
Bone marrow transplantation (BMT) patients experience pro-
longed neutropenia, resulting in protracted lengths of stay. Fami-
lies/caregivers wish to show psychological support by increased
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visiting. Nurses advocate to protect their patient’s physical health
by enforcing strict visitation guidelines.
The BMT unit at our NCI Comprehensive Cancer Center
(NCI-CCC) allows overnight stays for only speciﬁc patient/family
needs, such as critical illness or language translation, due to the
small size of laminar airﬂow rooms (LAF). The 2003 CDC Guide-
lines for Preventing Health Care Associated Pneumonia no longer
support the need of LAF in BMT patient rooms. Release of this
information coincided with our plan to remodel inpatient rooms at
our center thus presenting an opportune time to consider imple-
menting a change in our existing policy.
The purpose of this abstract is to present ﬁndings of a review of
visiting policies and practices at 62 NCI-CCC BMT units. A
comprehensive review of the literature on visiting hours in BMT
units yielded no available data. Contact was made with all NCI-
CCC with BMT units to inquire about their practices, speciﬁcally
about what visitor hours are used in the BMT unit, whether
children are allowed to visit, and whether caregivers can stay
overnight. Data were entered using Excel software. Ranges ran
from “completely open” to structured visiting hours and precise
statements to prevent overnight stays.
This presentation will demonstrate that visiting practices on
BMT units throughout the United States vary greatly and speciﬁc
results will be presented. A recommendation for liberalizing visit-
ing hours based on community standards, CDC recommendations,
and patient/family satisfaction will be made.
293
ANOTHER SEASON OF SNEEZING: RESPIRATORY SYNCYTIAL VIRUS
REVISITED
Meyers, A.L., Neumann, J., Gonzalez, V. University of Texas M.D.
Anderson Cancer Center, Houston, TX.
Respiratory viral infections, such as respiratory syncytial virus
(RSV), frequently cause acute respiratory illness and are associated
with high morbidity and mortality rates. RSV causes yearly and
seasonal epidemics of upper and lower respiratory infections. The
occurrence can run throughout the year, but there are typically
widespread outbreaks during the winter months, peaking in Janu-
ary and February. On our 52-bed inpatient unit, patients are
screened by nurses on admission and daily by the health care team
for respiratory symptoms (eg, cough, wheezing, fever, runny nose,
sore throat). A nasal wash using rapid antigen and a viral culture is
performed on any patient experiencing symptoms. Contact isola-
tion is initiated before results are available to decrease transmission
to other patients.
During this past winter (2003–2004), our BMT unit experienced
an increase of RSV infections compared to previous years, and this
constituted an outbreak. Strict infection control measures were
implemented consisting of cohorting patients in one area with only
low-risk patients in that area, limiting staff caring for RSV patients,
and screening patients, staff, and visitors for upper respiratory
symptoms. This season, we currently have several cases of com-
munity-acquired RSV that started as early as July. We have devel-
oped a multidisciplinary task force to address prevention and con-
trol strategies for nosocomial spread. The task force had
representation from nursing, physicians, infection control, micro-
biology, research, and employee health. The goals of this group are
to increase the awareness of staff throughout the institution and to
develop a policy for prevention and management. In-service edu-
cation is provided to the emergency room, outpatient clinics, and
inpatient ﬂoors that care for immunocompromised patients and
include signs and symptoms, treatment, and prevention of RSV.
The process of handling an epidemic, treatment, signs and symp-
toms, screening, and nosocomial versus community acquired will
be critically examined in this presentation.
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OUTPATIENT TOTAL BODY IRRADIATION (TBI) IN THE PEDIATRIC
BONE MARROW TRANSPLANTATION PATIENT
Giller, R.H., Van Stelle, J.L., Hinote, M.J., Hild, E., Malcolm, J.,
Kissane, R., Quinones, R. The Children’s Hospital, Denver, CO.
The bone marrow transplantation (BMT) program at The Chil-
dren’s Hospital of Denver began in 1994. At the beginning of the
program, patients were admitted to the inpatient BMT unit for the
entire preparative regimen for transplantation, including total
body irradiation (TBI). Patients receive 2 fractions of TBI for 3
consecutive days (1200 cGy total dose). This process required
thorough planning and organization on the part of the nurses,
doctors, social workers, and families, because radiation therapy is
done at an off-site location. When TBI was a routine part of the
inpatient preparative plan, patients and families had to be trans-
ported to radiation by ambulance. The estimated savings of out-
patient TBI is about a third of what it would cost to admit the
patient to the hospital for the 3 days of radiation therapy.
Due to this complex and costly process, a plan was formulated in
1996 to defer hospital admission for 3 days and allow patients to
receive their TBI on an outpatient basis. Admission to the BMT
unit takes place after the completion of irradiation if the individual
medically tolerates outpatient TBI. After each fraction of TBI,
patients are expected to visit the outpatient BMT clinic for an
exam, IV ﬂuids, and antiemetics or possible blood/platelet trans-
fusions as needed for support. We have found it necessary to admit
only about 5% of the 84 patients who received TBI due to com-
plications. The process of outpatient TBI can also be beneﬁcial to
the family as a whole by allowing the children to spend more time
with their family members in their familiar and comfortable home
environment.
Overall, outpatient TBI can be a widely successful process ﬁnan-
cially and emotionally for patients, families, and institutions par-
ticipating in such programs.
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HLA MADE SIMPLE: CHROMOSOMES, GENES, AND ALLELES, OH MY
Mattox, S., Stewart, D., Gibson-Steed, M. St. Jude Childrens Research
Hospital, Memphis, TN.
Patients who are candidates for allogeneic hematopoietic stem
cell transplantation (HSCT) must be HLA typed to ﬁnd the best
donor. It is important for the nursing staff of a HSCT unit to
understand HLA and how the recipient is matched to the donor.
St. Jude has incorporated haploidentical donor transplantations
into their HSCT program. Knowledge of the recipient and donor
HLA match can be beneﬁcial for the nursing regarding potential
complications during tranpslant and issues revolving around en-
graftment.
The stem cell transplantation nursing staff was provided a simple
written overview of HLA. This information included the basics of
chromosomes, genes, and alleles; how to read a HLA report; and
visual aids that showed examples of how the recipient and donor
might match depending on the type of transplantation performed.
Providing the staff with visual aids of the different recipient/donor
scenarios in HSCT clearly helped their understanding of the impor-
tance of HLA typing, donor matching, and potential complications.
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THE ROLE OF PATIENT EDUCATION IN THE SAFE MANAGEMENT OF
AUTOLOGOUS HSCT PATIENTS IN AN OUTPATIENT SETTING
Hamelin, L., McDiarmid, S., Huebsch, L. Ottawa Hospital, General
Campus, Ottawa, ON, Canada.
The Ottawa Hospital accommodates care for patients undergo-
ing high-dose chemotherapy with autologous stem cell support
(HSCT) on an outpatient basis. Nursing has played a pivotal role
in facilitating the transition of complex patients from an inpatient
venue to an outpatient venue. Although advances in pain and
nausea control and infection prevention have enabled patients to
undergo intense therapy, it is the continuous, comprehensive
teaching that patients and caregivers receive that ensures the safety
of outpatient care. Morbidity and mortality associated with an
infectious complication during the pancytopenic period remains
the greatest risk in transplantation; however, informed patients and
caregivers are capable of recognizing symptoms that may require
immediate attention. According to Talcott and colleagues’ criteria
for assessing risk in patients with febrile neutropenia, our group of
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